The invisible hero of modern medicine is the laboratory: most clinical decisions take shape in the light of a test result. Yet the volume of data laboratories produce is growing far faster than the human time available to interpret it. A family physician may start the day with dozens of test results; the number of parameters passing before an internist can run into the thousands. This picture points to one of the areas where AI can make its most concrete contribution to healthcare: supporting the interpretation of laboratory results.
What can AI actually do here?
The key word is "support". AI's role with laboratory data is not to interpret in the physician's place, but to direct the physician's attention to the right place. In practice, this translates into a few concrete capabilities:
- Prioritization: surfacing the results that need attention from among the dozens arriving each day, so the critical one does not drown in a crowd of normals.
- Pattern detection: pointing out combinations of parameters that look near-normal individually but paint a meaningful picture together.
- The time dimension: comparing against the patient's past results to make visible a value that stays within the reference range yet shows a trend worth noticing.
These capabilities share one common denominator: none of them makes a diagnosis. All of them steer the physician's limited time toward where it creates the most value.
Drawing the limits honestly
To do AI-assisted interpretation justice, its limits must be stated just as clearly. Laboratory values cannot be read apart from clinical context: the same number means entirely different things at different ages, with different medications, or alongside different comorbidities. Information the model cannot reach — how the patient feels that day, a newly started drug, a physical finding — is an indispensable part of interpretation. Differences between the data a model was trained on and the population it meets in the field can also quietly erode performance. A responsible system therefore speaks the language of drawing attention rather than passing verdicts, and submits every inference to the physician's review.
Afinitem's work in this space
This is the vision we are pursuing as well. FNN Blood Analysis is our R&D project in development, aiming at automatic analysis of blood test results with feedforward neural networks and deep learning models. It is not a finished product yet; it is taking shape precisely within the frame drawn in this article — as a layer that supports the clinician's assessment. As we mature the project, our priority is an approach that is verifiable, trustworthy and respectful of clinical workflow, rather than flashy promises.
Workflow integration: the hardest mile
Whether a technically successful model creates value in the field depends on how gracefully it settles into clinical workflow. The first danger is alert fatigue: a system that flags every deviation soon becomes a system whose flags nobody reads. Carefully tuned attention thresholds and severity grading are preconditions for longevity. The second danger is context rupture: if the physician must open a separate screen to see the AI assessment, most days that assessment will go unseen — support must live inside the screen where results are already reviewed. The third, least discussed, is feedback: letting clinicians mark a flag as useful or noise effortlessly turns everyday use into the system's ongoing education.
Laboratory data will keep growing, and our capacity to make sense of it must grow at the same pace. If you would like to discuss the role AI will play in that balance, or share your questions and views, reach out to us.